$CAC

CAMDEN NATIONAL CORP (CAC): Results of Operations and Financial Condition

CAMDEN NATIONAL CORP (CAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsreleaseq226.htm EX-99.1 Document CONTACT: Michael Archer Executive Vice President Chief Financial Officer Camden National Corporation (800) 860-8821 marcher@CamdenNational.bank FOR IMMEDIATE RELEASE Camden National Corporation Reports Record Quarterly Net I

Original reporting
Published Jul 28, 2026, 12:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 12:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CAC
Bullish
high confidence
Mentioned
$CAC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CACBullishMed
01

Why it matters

Key decision inputs for traders are the profitability drivers (net income, EPS, net interest margin), credit quality (net charge-offs, past-due and non-performing ratios, ACL coverage), and capital and liquidity posture (capital ratios, loan-to-deposit, deposit mix).

02

Market read

Provides quantified quarterly performance and balance-sheet updates that can drive near-term repricing for CAC and inform regional bank factor positioning.

03

What to watch

The release emphasizes non-GAAP metrics and mark accretion changes; traders may want to separate core NIM trends from fair-value/mark-to-market effects and watch the committed loan pipeline conversion.

Relevance 7/10Novelty 8/10Timing: today’s SEC 8-K earnings release, before/around market open

Background

The company filed an SEC Form 8-K (Item 2.02) with its Q2 2026 results and financial condition, including operating performance, credit metrics, capital ratios, and capital return.

Company-level read

Ticker impact

$CACBullishHigh confidence
Context

Camden National reported Q2 2026 net income of $23.0M and diluted EPS of $1.35, plus NIM expansion to 3.26%.

Expected impact

Near-term bias modestly positive if investors focus on NIM expansion, record earnings, and stable credit metrics; magnitude likely limited absent new guidance.

Evidence & confidence

This is a primary-source 8-K earnings release with multiple quantified drivers (net income, EPS, NIM, efficiency, credit losses, capital ratios) and no indication of a surprise deterioration.

Market effects

Regional bank read-through: improving funding costs and stable credit quality support the narrative of resilient net interest income.

Camden, Maine-based lender results may be a small positive signal for local banking sentiment.

Limited global relevance; primarily impacts US regional bank positioning and rate-sensitive bank factor exposure.

Counterpoint

Despite record earnings, loans grew only 1% and deposits declined 1%, so the sustainability of momentum could be questioned if funding pressure returns.

Key entities

  • Camden National Corporation

    NASDAQ-listed regional bank reporting Q2 2026 record net income and EPS, with NIM expansion and stable asset quality.

  • Northway Financial, Inc.

    Acquired January 1, 2025; the release attributes part of the six-month results to integration and earnings contribution.

Related articles

$CACMed

Camden National Q2 Earnings Call Highlights

Camden National (NASDAQ:CAC) Q2 earnings call covered loan and deposit trends and guidance. Archer said quarterly cash flows modeled at about $35M from investments and $170M to $180M from loans, with new loan pricing in the low-6% to 6.5% range. Noninterest income rose 21% to $14.5M; Q3 outlook $13.5M to $14M. Assets were $7B; deposits $5.6B; tangible book value per share $31.64.

Med

Camden National Corporation Q2 2026 Earnings Call Summary

Camden National Corporation reported record Q2 2026 net income of $23 million, citing loan growth, a 2 bp net interest margin expansion from lower funding costs and deposit mix, and 21% linked-quarter fee income growth. HELOC balances rose 23% YoY, and management expects Q3 NIM up 5 to 10 bp, noninterest income $13.5m to $14m, and expenses $37m to $38m.

$CACMedAI 8/10

Camden National Corporation Reports Record Quarterly Net Income of $23.0 Million and Diluted EPS of $1.35 for the Second Quarter of 2026

Camden National Corporation (NASDAQ: CAC) reported Q2 2026 net income of $23.0 million and diluted EPS of $1.35 for the quarter ended June 30, 2026. For the first six months, net income was $44.9 million and diluted EPS $2.64. The company cited 3% annualized loan growth, net interest margin at 3.26%, and a $0.42/share dividend, plus a Q2 buyback of 52,000 shares.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.